N/A
N=756
Pap Smear Collection With the Papette Brush
Cervical Cancer Screening
Bottom Line
View on ClinicalTrials.gov: NCT05034614 ↗Enrolled (actual)
756
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcome: Primary: Specimen Adequacy — 335; 371 Participants — p=.75
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Papette brush collection (Diagnostic_test); Spatula/cytology brush collection (Diagnostic_test)
- Age
- Adult · 21+ yrs
- Sex
- Female
- Sponsor
- Mayo Clinic
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Specimen Adequacy |
335; 371 | .75 |
| SECONDARY Cervical Bleeding With Collection |
0; 0 | — |
| SECONDARY Collection Time |
— | — |
| SECONDARY Perceived Pain |
— | — |
Summary
This research study is comparing Pap smear collection techniques using the Papette brush to traditional spatula and cytology brush for cervical cancer screening
Eligibility Criteria
Inclusion Criteria
- Adult women, aged 21-64 years old.
- Have given consent for medical records to be accessed.
- Who will have a Pap smear exam in CIM from July 2021 through June 2022.
Exclusion Criteria
- Women, age 64.
- Has vaginal spotting present during cervical sampling.
- Did not give consent to have medical records accessed.
Data sourced from ClinicalTrials.gov (NCT05034614). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.